More opioid makers are going bankrupt - and it's showing up in the alternative data Big Pharma is finally being held accountable for their actions, and we have the data to prove it. Jon Marino 1.23.20 9:58 PM Markets
It's go-time for Casper's IPO - and this is the mattress startup's alternative data Mattress startup Casper is going from DTC retailer to brick-and-mortar stores. Since it's prepping an IPO, it's time to look at the alternative data points that characterize the company's growth. Jon Marino 1.10.20 7:27 PM Markets
Despite the ad, Peloton's product reviews are soaring and it may be our fault New Peloton customers are giving their new bikes favorable reviews after years of sagging scores. This all comes after we reported on some unhappy customers. Joshua Fruhlinger 12.4.19 6:12 PM Features
A brief history of why Martin Shkreli got banned from Twitter The following is an excerpt from SMIRK, a memoir of journalist Christie Smythe's unusual relationship with "Pharma Bro" Martin Shkreli. It should be viewed as opinion. You can read more at www.smirk-book.com. Christie Smythe 11.23.22 12:25 AM Outcasts
Here's why Peloton is bouncing back just in time for the holidays Don't look now, but Peloton's stock is white-hot, and it hasn't even reported holiday sales yet. Jon Marino 12.2.19 11:00 AM Markets
Victoria's Secret may bounce back on solid data Between bad press and bad data, L Brands has had a rough 2019 - but is there hope in the holidays? Jon Marino 11.20.19 10:18 AM Markets
Juul job postings tumble 90% as vape king slashes headcount All that growth, now up in smoke. Jon Marino 11.12.19 2:23 PM Innovation
"Repulsive," "reptilian," "diseased": What John D. Rockefeller had in common with Martin Shkreli The following is an excerpt from SMIRK, a memoir of journalist Christie Smythe's unusual relationship with "Pharma Bro" Martin Shkreli. It should be viewed as opinion. You can read more at www.smirk-book.com. Christie Smythe 11.20.22 5:13 PM Features